Cover Image
Market Research Report

Indonesia Pharmaceuticals & Healthcare Q1 2020

Published by Fitch Solutions, Inc. Product code 177846
Published Content info 88 Pages
Delivery time: 1-2 business days
Back to Top
Indonesia Pharmaceuticals & Healthcare Q1 2020
Published: November 19, 2019 Content info: 88 Pages

Key View:

Having established itself as a key pharmaceutical market in South East Asia, Indonesia is already a host to many multinationals and domestic drugmakers. Authorities are also investing in regulatory improvement initiatives, which will complement their efforts to achieve universal healthcare coverage. However, some foreign players may remain wary of committing to the market due to the prevalence of counterfeit medicines, low per capital purchasing power and the uncertain funding base.

Table of Contents
Product Code: SSID03_20200101

Table of Contents

Key View


Industry Forecast

  • Pharmaceutical Market Forecast
  • Healthcare Market Forecast
  • Prescription Drug Market Forecast
  • Patented Drug Market Forecast
  • Generic Drug Market Forecast
  • OTC Medicine Market Forecast
  • Pharmaceutical Trade Forecast

Industry Risk/Reward Index

  • Asia Pacific Innovative Pharmaceuticals Risk/Reward Index
  • Indonesia Innovative Pharmaceuticals Risk/Reward Index

Regulatory Development

  • Regulatory Review

Market Overview

Competitive Landscape

Company Profile

  • Bayer
  • Darya-Varia Group
  • GlaxoSmithKline
  • Indofarma
  • Kimia Farma
  • MSD
  • Merck Group
  • Novartis
  • Pfizer
Back to Top